Name: RETA Peptide
Brand: peptidesskin
Price: 89.00 USD
Availability: InStock

Question 1

Is retatrutide available for purchase?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Retatrutide is "}, {"type"=>"text", "value"=>"not approved for commercial medical use", "bold"=>true}, {"type"=>"text", "value"=>" and is not legally sold as a prescription medication."}]}]}

Question 2

Who should not use retatrutide?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Retatrutide is "}, {"type"=>"text", "value"=>"not intended for human use outside clinical trials", "bold"=>true}, {"type"=>"text", "value"=>" and should not be used by individuals with certain medical conditions."}]}]}

Question 3

Is retatrutide better than Ozempic?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Retatrutide is being researched as a "}, {"type"=>"text", "value"=>"next-generation metabolic therapy", "bold"=>true}, {"type"=>"text", "value"=>", but direct comparisons with Ozempic are still limited."}]}]}

Question 4

What are the side effects of retatrutide?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Reported side effects in studies include "}, {"type"=>"text", "value"=>"nausea, vomiting, diarrhea, constipation, and reduced appetite", "bold"=>true}, {"type"=>"text", "value"=>", especially during dose escalation."}]}]}

Question 5

How effective is retatrutide?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Clinical research indicates retatrutide may support "}, {"type"=>"text", "value"=>"significant body-weight reduction", "bold"=>true}, {"type"=>"text", "value"=>", depending on dose and study duration."}]}]}

Question 6

Is retatrutide used for weight loss?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Retatrutide is being "}, {"type"=>"text", "value"=>"studied for weight management and obesity", "bold"=>true}, {"type"=>"text", "value"=>" in clinical research settings."}]}]}

Question 7

Is retatrutide approved by the FDA?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"No, retatrutide is "}, {"type"=>"text", "value"=>"not FDA-approved", "bold"=>true}, {"type"=>"text", "value"=>" and remains under "}, {"type"=>"text", "value"=>"clinical investigation", "bold"=>true}, {"type"=>"text", "value"=>"."}]}]}

Question 8

How does retatrutide work?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Retatrutide works by "}, {"type"=>"text", "value"=>"reducing appetite, improving metabolic regulation, and increasing energy expenditure", "bold"=>true}, {"type"=>"text", "value"=>" through multiple hormonal pathways."}]}]}

Question 9

What makes retatrutide unique?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Retatrutide is a "}, {"type"=>"text", "value"=>"triple-agonist therapy", "bold"=>true}, {"type"=>"text", "value"=>" that targets "}, {"type"=>"text", "value"=>"GLP-1, GIP, and glucagon receptors", "bold"=>true}, {"type"=>"text", "value"=>" involved in appetite, metabolism, and energy balance."}]}]}

Question 10

What is retatrutide?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Retatrutide is an "}, {"type"=>"text", "value"=>"investigational injectable compound", "bold"=>true}, {"type"=>"text", "value"=>" studied for "}, {"type"=>"text", "value"=>"obesity, weight management, and metabolic diseases", "bold"=>true}, {"type"=>"text", "value"=>", including type 2 diabetes."}]}]}

Question 11

How should lyophilized Retatrutide be stored?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Lyophilized Retatrutide should be stored at -20°C in a dry environment away from light. Once reconstituted for research, it is typically stored at 4°C, though stability depends on the solvent used and laboratory handling protocols.
    "}]}]}

Question 12

is Retatrutide available for human use?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"No. Retatrutide is an experimental chemical. The product sold by Peptides Skin is strictly for in-vitro laboratory research and is not approved for human consumption or therapeutic use.
    "}]}]}

Question 13

How does RETA differ from Semaglutide or Tirzepatide?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Semaglutide is a single agonist (GLP-1), and Tirzepatide is a dual agonist (GLP-1/GIP). Retatrutide introduces a third component—Glucagon receptor agonism—distinguishing it from earlier generations of peptides.
    "}]}]}

Question 14

What is the mechanism of action for Retatrutide?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Retatrutide acts as a triple-hormone-receptor agonist, simultaneously targeting GIP, GLP-1, and Glucagon receptors. This unique action is researched for its synergistic effects on metabolic regulation.
    "}]}]}

Question 15

What are the most common side effects of tirzepatide and retatrutide?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"The most commonly reported side effects for both drugs are "}, {"type"=>"text", "value"=>"gastrointestinal", "bold"=>true}, {"type"=>"text", "value"=>", including nausea, vomiting, diarrhea, constipation, and decreased appetite. These are usually mild to moderate and improve over time, but more serious risks are still being monitored, especially for retatrutide where long-term data is limited."}]}]}

Question 16

Are tirzepatide and retatrutide the same as Zepbound or Mounjaro?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"tirzepatide is the "}, {"type"=>"text", "value"=>"active ingredient", "bold"=>true}, {"type"=>"text", "value"=>" in branded medications like Mounjaro (for diabetes) and Zepbound (for weight loss and sleep apnea). Retatrutide does not yet have an approved brand name because it’s still in clinical development."}]}]}

Question 17

Which is better for weight loss: tirzepatide or retatrutide?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"early studies suggest "}, {"type"=>"text", "value"=>"retatrutide may produce slightly higher average weight loss", "bold"=>true}, {"type"=>"text", "value"=>" (around 24% of body weight) compared with the ~20–21% seen in tirzepatide trials. But tirzepatide has extensive Phase 3 data and real-world experience, while retatrutide is still in trials and not yet directly compared in a large head-to-head study."}]}]}

Question 18

what is the difference between tirzepatide and retatrutide?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"Tirzepatide is a "}, {"type"=>"text", "value"=>"dual agonist", "bold"=>true}, {"type"=>"text", "value"=>" that targets GLP-1 and GIP receptors, while retatrutide is a "}, {"type"=>"text", "value"=>"triple agonist", "bold"=>true}, {"type"=>"text", "value"=>" that targets GLP-1, GIP, and glucagon receptors. Both influence appetite, metabolism, and blood sugar, but retatrutide’s extra glucagon activity may contribute to even greater fat-loss in early trials. Tirzepatide is already approved and widely used; retatrutide is still experimental."}]}]}

Question 19

How much weight loss can you expect with retatrutide?

Accepted Answer

{"type"=>"root", "children"=>[{"type"=>"paragraph", "children"=>[{"type"=>"text", "value"=>"In Phase 2 trials, people taking retatrutide for obesity lost "}, {"type"=>"text", "value"=>"up to ~24% of their starting body weight", "bold"=>true}, {"type"=>"text", "value"=>" over 48 weeks on higher doses, which is slightly more than what has been seen with current approved drugs. These results are still considered preliminary until Phase 3 data is complete."}]}]}

Product Name	Reta (Research Grade)
Label / Common	RETA / LY3437943
CAS Number	2381089-83-2
Molecular Formula	C221H342N46O68
Molecular Weight	~4731 g/mol
Target Receptors	GIP / GLP-1 / Glucagon (GCG)
Purity	≥99% (HPLC verified; per lot CoA)
Form	Lyophilized White Powder
Endotoxin Level	< 1.0 EU/mg (where stated on lot documentation)

RETA Peptide

Reta Peptide , Research Grade Triple Agonist (GIP / GLP-1 / Glucagon), ≥99% HPLC Purity

Available Strengths

Product Details

Shipping

What Is Reta?

Reta Mechanism of Action (Research Context)

Reta vs Tirz (Research Comparison)

Product Specifications

Quality Control & Documentation (CoA)

Storage & Handling (Research Context)

Frequently Asked Questions (FAQ)

What is reta peptide?

What is LY3437943?

Is retaFDA approved?

Is reta a peptide or a steroid?

What receptors does reta target?

Reta vs tirz — what’s the difference?

How is reta purity verified?

Legal & Compliance Notice

Disclaimer: Sold strictly for laboratory research use only. Not for human consumption, medical treatment, diagnostic procedures, or veterinary use.